Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

SHANGHAI, Aug. 30, 2023 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation…

Chroma ATE Showcases Advanced Test Technology to Propel the AI Revolution at SEMICON Taiwan 2023

TAOYUAN, Aug. 30, 2023 /PRNewswire/ — Chroma ATE Inc., a leading provider of automated test equipment,…

ZTO Reports Second Quarter 2023 Unaudited Financial Results

Expanded Market Share to 23.5% with 7.7 Billion ParcelsGrew Adjusted Net Income 43.9% to Reach RMB2.5…

CGTN:”The Art Beat” Season II- Eight Artists Offer Fresh Takes on the China Story

BEIJING, Aug. 30, 2023 /PRNewswire/ — The Art Beat Season II premiered on CGTN television and various…

Addentax Group Corp. Regains Compliance with Nasdaq Minimum Bid Price Requirement

SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ — Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG),…